ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Clinical Endpoint Adjudication (CEA) Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-5V18101
Home | Market Reports | Health| Health Foundations & Medical Research
Global Clinical Endpoint Adjudication CEA Market Research Report 2024
BUY CHAPTERS

Global Clinical Endpoint Adjudication (CEA) Market Research Report 2024

Code: QYRE-Auto-5V18101
Report
August 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CEA
ICON
Medidata Solutions
Clario
Syneos Health
Advarra
Medpace
Sitero
WCG Clinical
Voiant
IQVIA
Ethical
Banook Group
Judi for Adjumination
CISYS LifeSciences
Crucial Data Solutions
TCell Clinical Services
George Clinical
ITREAS
Exom Group
Cardialysisv

Clinical Endpoint Adjudication (CEA) Market

Clinical Endpoint Adjudication (CEA) is a crucial process in clinical trials, particularly those involving complex endpoints such as major adverse cardiovascular events, oncology, or other conditions where subjective judgment may be required.
CEA services ensure the unbiased, consistent, and accurate assessment of clinical trial endpoints. This process enhances the reliability and credibility of trial results by providing an independent review of critical events, which may impact the study's outcomes. By integrating CEA services into clinical trials, sponsors can ensure that critical endpoints are evaluated rigorously and objectively, leading to more reliable and valid study outcomes.
The global Clinical Endpoint Adjudication (CEA) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Clinical Endpoint Adjudication (CEA) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Clinical Endpoint Adjudication (CEA) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Clinical Endpoint Adjudication (CEA) in Drug Clinical Trials is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Clinical Endpoint Adjudication (CEA) include ICON, Medidata Solutions, Clario, Syneos Health, Advarra, Medpace, Sitero, WCG Clinical, Voiant, IQVIA, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Clinical Endpoint Adjudication (CEA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Endpoint Adjudication (CEA).
The Clinical Endpoint Adjudication (CEA) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Endpoint Adjudication (CEA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Endpoint Adjudication (CEA) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Clinical Endpoint Adjudication (CEA) Market Report

Report Metric Details
Report Name Clinical Endpoint Adjudication (CEA) Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ICON, Medidata Solutions, Clario, Syneos Health, Advarra, Medpace, Sitero, WCG Clinical, Voiant, IQVIA, Ethical, Banook Group, Judi for Adjumination, CISYS LifeSciences, Crucial Data Solutions, TCell Clinical Services, George Clinical, Cardialysisv, ITREAS, Exom Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Clinical Endpoint Adjudication (CEA) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Clinical Endpoint Adjudication (CEA) Market report?

Ans: The main players in the Clinical Endpoint Adjudication (CEA) Market are ICON, Medidata Solutions, Clario, Syneos Health, Advarra, Medpace, Sitero, WCG Clinical, Voiant, IQVIA, Ethical, Banook Group, Judi for Adjumination, CISYS LifeSciences, Crucial Data Solutions, TCell Clinical Services, George Clinical, Cardialysisv, ITREAS, Exom Group

What are the Application segmentation covered in the Clinical Endpoint Adjudication (CEA) Market report?

Ans: The Applications covered in the Clinical Endpoint Adjudication (CEA) Market report are Drug Clinical Trials, Medical Device Clinical Trials, Others

What are the Type segmentation covered in the Clinical Endpoint Adjudication (CEA) Market report?

Ans: The Types covered in the Clinical Endpoint Adjudication (CEA) Market report are Efficacy Endpoints, Safety Endpoints

Recommended Reports

Clinical Trials & Services

Medical Devices & Endoscopy

Cancer & Precision Medicine

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Endpoint Adjudication (CEA) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Efficacy Endpoints
1.2.3 Safety Endpoints
1.3 Market by Application
1.3.1 Global Clinical Endpoint Adjudication (CEA) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Clinical Trials
1.3.3 Medical Device Clinical Trials
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Endpoint Adjudication (CEA) Market Perspective (2019-2030)
2.2 Global Clinical Endpoint Adjudication (CEA) Growth Trends by Region
2.2.1 Global Clinical Endpoint Adjudication (CEA) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clinical Endpoint Adjudication (CEA) Historic Market Size by Region (2019-2024)
2.2.3 Clinical Endpoint Adjudication (CEA) Forecasted Market Size by Region (2025-2030)
2.3 Clinical Endpoint Adjudication (CEA) Market Dynamics
2.3.1 Clinical Endpoint Adjudication (CEA) Industry Trends
2.3.2 Clinical Endpoint Adjudication (CEA) Market Drivers
2.3.3 Clinical Endpoint Adjudication (CEA) Market Challenges
2.3.4 Clinical Endpoint Adjudication (CEA) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Endpoint Adjudication (CEA) Players by Revenue
3.1.1 Global Top Clinical Endpoint Adjudication (CEA) Players by Revenue (2019-2024)
3.1.2 Global Clinical Endpoint Adjudication (CEA) Revenue Market Share by Players (2019-2024)
3.2 Global Clinical Endpoint Adjudication (CEA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Endpoint Adjudication (CEA) Revenue
3.4 Global Clinical Endpoint Adjudication (CEA) Market Concentration Ratio
3.4.1 Global Clinical Endpoint Adjudication (CEA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Endpoint Adjudication (CEA) Revenue in 2023
3.5 Global Key Players of Clinical Endpoint Adjudication (CEA) Head office and Area Served
3.6 Global Key Players of Clinical Endpoint Adjudication (CEA), Product and Application
3.7 Global Key Players of Clinical Endpoint Adjudication (CEA), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Endpoint Adjudication (CEA) Breakdown Data by Type
4.1 Global Clinical Endpoint Adjudication (CEA) Historic Market Size by Type (2019-2024)
4.2 Global Clinical Endpoint Adjudication (CEA) Forecasted Market Size by Type (2025-2030)
5 Clinical Endpoint Adjudication (CEA) Breakdown Data by Application
5.1 Global Clinical Endpoint Adjudication (CEA) Historic Market Size by Application (2019-2024)
5.2 Global Clinical Endpoint Adjudication (CEA) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Clinical Endpoint Adjudication (CEA) Market Size (2019-2030)
6.2 North America Clinical Endpoint Adjudication (CEA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clinical Endpoint Adjudication (CEA) Market Size by Country (2019-2024)
6.4 North America Clinical Endpoint Adjudication (CEA) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Endpoint Adjudication (CEA) Market Size (2019-2030)
7.2 Europe Clinical Endpoint Adjudication (CEA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clinical Endpoint Adjudication (CEA) Market Size by Country (2019-2024)
7.4 Europe Clinical Endpoint Adjudication (CEA) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Endpoint Adjudication (CEA) Market Size (2019-2030)
8.2 Asia-Pacific Clinical Endpoint Adjudication (CEA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clinical Endpoint Adjudication (CEA) Market Size by Region (2019-2024)
8.4 Asia-Pacific Clinical Endpoint Adjudication (CEA) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Endpoint Adjudication (CEA) Market Size (2019-2030)
9.2 Latin America Clinical Endpoint Adjudication (CEA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clinical Endpoint Adjudication (CEA) Market Size by Country (2019-2024)
9.4 Latin America Clinical Endpoint Adjudication (CEA) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Endpoint Adjudication (CEA) Market Size (2019-2030)
10.2 Middle East & Africa Clinical Endpoint Adjudication (CEA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clinical Endpoint Adjudication (CEA) Market Size by Country (2019-2024)
10.4 Middle East & Africa Clinical Endpoint Adjudication (CEA) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICON
11.1.1 ICON Company Details
11.1.2 ICON Business Overview
11.1.3 ICON Clinical Endpoint Adjudication (CEA) Introduction
11.1.4 ICON Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.1.5 ICON Recent Development
11.2 Medidata Solutions
11.2.1 Medidata Solutions Company Details
11.2.2 Medidata Solutions Business Overview
11.2.3 Medidata Solutions Clinical Endpoint Adjudication (CEA) Introduction
11.2.4 Medidata Solutions Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.2.5 Medidata Solutions Recent Development
11.3 Clario
11.3.1 Clario Company Details
11.3.2 Clario Business Overview
11.3.3 Clario Clinical Endpoint Adjudication (CEA) Introduction
11.3.4 Clario Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.3.5 Clario Recent Development
11.4 Syneos Health
11.4.1 Syneos Health Company Details
11.4.2 Syneos Health Business Overview
11.4.3 Syneos Health Clinical Endpoint Adjudication (CEA) Introduction
11.4.4 Syneos Health Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.4.5 Syneos Health Recent Development
11.5 Advarra
11.5.1 Advarra Company Details
11.5.2 Advarra Business Overview
11.5.3 Advarra Clinical Endpoint Adjudication (CEA) Introduction
11.5.4 Advarra Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.5.5 Advarra Recent Development
11.6 Medpace
11.6.1 Medpace Company Details
11.6.2 Medpace Business Overview
11.6.3 Medpace Clinical Endpoint Adjudication (CEA) Introduction
11.6.4 Medpace Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.6.5 Medpace Recent Development
11.7 Sitero
11.7.1 Sitero Company Details
11.7.2 Sitero Business Overview
11.7.3 Sitero Clinical Endpoint Adjudication (CEA) Introduction
11.7.4 Sitero Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.7.5 Sitero Recent Development
11.8 WCG Clinical
11.8.1 WCG Clinical Company Details
11.8.2 WCG Clinical Business Overview
11.8.3 WCG Clinical Clinical Endpoint Adjudication (CEA) Introduction
11.8.4 WCG Clinical Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.8.5 WCG Clinical Recent Development
11.9 Voiant
11.9.1 Voiant Company Details
11.9.2 Voiant Business Overview
11.9.3 Voiant Clinical Endpoint Adjudication (CEA) Introduction
11.9.4 Voiant Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.9.5 Voiant Recent Development
11.10 IQVIA
11.10.1 IQVIA Company Details
11.10.2 IQVIA Business Overview
11.10.3 IQVIA Clinical Endpoint Adjudication (CEA) Introduction
11.10.4 IQVIA Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.10.5 IQVIA Recent Development
11.11 Ethical
11.11.1 Ethical Company Details
11.11.2 Ethical Business Overview
11.11.3 Ethical Clinical Endpoint Adjudication (CEA) Introduction
11.11.4 Ethical Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.11.5 Ethical Recent Development
11.12 Banook Group
11.12.1 Banook Group Company Details
11.12.2 Banook Group Business Overview
11.12.3 Banook Group Clinical Endpoint Adjudication (CEA) Introduction
11.12.4 Banook Group Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.12.5 Banook Group Recent Development
11.13 Judi for Adjumination
11.13.1 Judi for Adjumination Company Details
11.13.2 Judi for Adjumination Business Overview
11.13.3 Judi for Adjumination Clinical Endpoint Adjudication (CEA) Introduction
11.13.4 Judi for Adjumination Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.13.5 Judi for Adjumination Recent Development
11.14 CISYS LifeSciences
11.14.1 CISYS LifeSciences Company Details
11.14.2 CISYS LifeSciences Business Overview
11.14.3 CISYS LifeSciences Clinical Endpoint Adjudication (CEA) Introduction
11.14.4 CISYS LifeSciences Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.14.5 CISYS LifeSciences Recent Development
11.15 Crucial Data Solutions
11.15.1 Crucial Data Solutions Company Details
11.15.2 Crucial Data Solutions Business Overview
11.15.3 Crucial Data Solutions Clinical Endpoint Adjudication (CEA) Introduction
11.15.4 Crucial Data Solutions Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.15.5 Crucial Data Solutions Recent Development
11.16 TCell Clinical Services
11.16.1 TCell Clinical Services Company Details
11.16.2 TCell Clinical Services Business Overview
11.16.3 TCell Clinical Services Clinical Endpoint Adjudication (CEA) Introduction
11.16.4 TCell Clinical Services Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.16.5 TCell Clinical Services Recent Development
11.17 George Clinical
11.17.1 George Clinical Company Details
11.17.2 George Clinical Business Overview
11.17.3 George Clinical Clinical Endpoint Adjudication (CEA) Introduction
11.17.4 George Clinical Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.17.5 George Clinical Recent Development
11.18 Cardialysisv
11.18.1 Cardialysisv Company Details
11.18.2 Cardialysisv Business Overview
11.18.3 Cardialysisv Clinical Endpoint Adjudication (CEA) Introduction
11.18.4 Cardialysisv Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.18.5 Cardialysisv Recent Development
11.19 ITREAS
11.19.1 ITREAS Company Details
11.19.2 ITREAS Business Overview
11.19.3 ITREAS Clinical Endpoint Adjudication (CEA) Introduction
11.19.4 ITREAS Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.19.5 ITREAS Recent Development
11.20 Exom Group
11.20.1 Exom Group Company Details
11.20.2 Exom Group Business Overview
11.20.3 Exom Group Clinical Endpoint Adjudication (CEA) Introduction
11.20.4 Exom Group Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
11.20.5 Exom Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
CEA
ICON
Medidata Solutions
Clario
Syneos Health
Advarra
Medpace
Sitero
WCG Clinical
Voiant
IQVIA
Ethical
Banook Group
Judi for Adjumination
CISYS LifeSciences
Crucial Data Solutions
TCell Clinical Services
George Clinical
ITREAS
Exom Group
Cardialysisv
List of Tables
 Table 1. Global Clinical Endpoint Adjudication (CEA) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Efficacy Endpoints
 Table 3. Key Players of Safety Endpoints
 Table 4. Global Clinical Endpoint Adjudication (CEA) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Clinical Endpoint Adjudication (CEA) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Clinical Endpoint Adjudication (CEA) Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Clinical Endpoint Adjudication (CEA) Market Share by Region (2019-2024)
 Table 8. Global Clinical Endpoint Adjudication (CEA) Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Clinical Endpoint Adjudication (CEA) Market Share by Region (2025-2030)
 Table 10. Clinical Endpoint Adjudication (CEA) Market Trends
 Table 11. Clinical Endpoint Adjudication (CEA) Market Drivers
 Table 12. Clinical Endpoint Adjudication (CEA) Market Challenges
 Table 13. Clinical Endpoint Adjudication (CEA) Market Restraints
 Table 14. Global Clinical Endpoint Adjudication (CEA) Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Clinical Endpoint Adjudication (CEA) Market Share by Players (2019-2024)
 Table 16. Global Top Clinical Endpoint Adjudication (CEA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Endpoint Adjudication (CEA) as of 2023)
 Table 17. Ranking of Global Top Clinical Endpoint Adjudication (CEA) Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Clinical Endpoint Adjudication (CEA) Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Clinical Endpoint Adjudication (CEA), Headquarters and Area Served
 Table 20. Global Key Players of Clinical Endpoint Adjudication (CEA), Product and Application
 Table 21. Global Key Players of Clinical Endpoint Adjudication (CEA), Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Clinical Endpoint Adjudication (CEA) Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Clinical Endpoint Adjudication (CEA) Revenue Market Share by Type (2019-2024)
 Table 25. Global Clinical Endpoint Adjudication (CEA) Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Clinical Endpoint Adjudication (CEA) Revenue Market Share by Type (2025-2030)
 Table 27. Global Clinical Endpoint Adjudication (CEA) Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Clinical Endpoint Adjudication (CEA) Revenue Market Share by Application (2019-2024)
 Table 29. Global Clinical Endpoint Adjudication (CEA) Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Clinical Endpoint Adjudication (CEA) Revenue Market Share by Application (2025-2030)
 Table 31. North America Clinical Endpoint Adjudication (CEA) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Clinical Endpoint Adjudication (CEA) Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Clinical Endpoint Adjudication (CEA) Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Clinical Endpoint Adjudication (CEA) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Clinical Endpoint Adjudication (CEA) Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Clinical Endpoint Adjudication (CEA) Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Clinical Endpoint Adjudication (CEA) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Clinical Endpoint Adjudication (CEA) Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Clinical Endpoint Adjudication (CEA) Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Clinical Endpoint Adjudication (CEA) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Clinical Endpoint Adjudication (CEA) Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Clinical Endpoint Adjudication (CEA) Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Clinical Endpoint Adjudication (CEA) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Clinical Endpoint Adjudication (CEA) Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Clinical Endpoint Adjudication (CEA) Market Size by Country (2025-2030) & (US$ Million)
 Table 46. ICON Company Details
 Table 47. ICON Business Overview
 Table 48. ICON Clinical Endpoint Adjudication (CEA) Product
 Table 49. ICON Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 50. ICON Recent Development
 Table 51. Medidata Solutions Company Details
 Table 52. Medidata Solutions Business Overview
 Table 53. Medidata Solutions Clinical Endpoint Adjudication (CEA) Product
 Table 54. Medidata Solutions Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 55. Medidata Solutions Recent Development
 Table 56. Clario Company Details
 Table 57. Clario Business Overview
 Table 58. Clario Clinical Endpoint Adjudication (CEA) Product
 Table 59. Clario Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 60. Clario Recent Development
 Table 61. Syneos Health Company Details
 Table 62. Syneos Health Business Overview
 Table 63. Syneos Health Clinical Endpoint Adjudication (CEA) Product
 Table 64. Syneos Health Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 65. Syneos Health Recent Development
 Table 66. Advarra Company Details
 Table 67. Advarra Business Overview
 Table 68. Advarra Clinical Endpoint Adjudication (CEA) Product
 Table 69. Advarra Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 70. Advarra Recent Development
 Table 71. Medpace Company Details
 Table 72. Medpace Business Overview
 Table 73. Medpace Clinical Endpoint Adjudication (CEA) Product
 Table 74. Medpace Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 75. Medpace Recent Development
 Table 76. Sitero Company Details
 Table 77. Sitero Business Overview
 Table 78. Sitero Clinical Endpoint Adjudication (CEA) Product
 Table 79. Sitero Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 80. Sitero Recent Development
 Table 81. WCG Clinical Company Details
 Table 82. WCG Clinical Business Overview
 Table 83. WCG Clinical Clinical Endpoint Adjudication (CEA) Product
 Table 84. WCG Clinical Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 85. WCG Clinical Recent Development
 Table 86. Voiant Company Details
 Table 87. Voiant Business Overview
 Table 88. Voiant Clinical Endpoint Adjudication (CEA) Product
 Table 89. Voiant Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 90. Voiant Recent Development
 Table 91. IQVIA Company Details
 Table 92. IQVIA Business Overview
 Table 93. IQVIA Clinical Endpoint Adjudication (CEA) Product
 Table 94. IQVIA Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 95. IQVIA Recent Development
 Table 96. Ethical Company Details
 Table 97. Ethical Business Overview
 Table 98. Ethical Clinical Endpoint Adjudication (CEA) Product
 Table 99. Ethical Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 100. Ethical Recent Development
 Table 101. Banook Group Company Details
 Table 102. Banook Group Business Overview
 Table 103. Banook Group Clinical Endpoint Adjudication (CEA) Product
 Table 104. Banook Group Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 105. Banook Group Recent Development
 Table 106. Judi for Adjumination Company Details
 Table 107. Judi for Adjumination Business Overview
 Table 108. Judi for Adjumination Clinical Endpoint Adjudication (CEA) Product
 Table 109. Judi for Adjumination Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 110. Judi for Adjumination Recent Development
 Table 111. CISYS LifeSciences Company Details
 Table 112. CISYS LifeSciences Business Overview
 Table 113. CISYS LifeSciences Clinical Endpoint Adjudication (CEA) Product
 Table 114. CISYS LifeSciences Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 115. CISYS LifeSciences Recent Development
 Table 116. Crucial Data Solutions Company Details
 Table 117. Crucial Data Solutions Business Overview
 Table 118. Crucial Data Solutions Clinical Endpoint Adjudication (CEA) Product
 Table 119. Crucial Data Solutions Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 120. Crucial Data Solutions Recent Development
 Table 121. TCell Clinical Services Company Details
 Table 122. TCell Clinical Services Business Overview
 Table 123. TCell Clinical Services Clinical Endpoint Adjudication (CEA) Product
 Table 124. TCell Clinical Services Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 125. TCell Clinical Services Recent Development
 Table 126. George Clinical Company Details
 Table 127. George Clinical Business Overview
 Table 128. George Clinical Clinical Endpoint Adjudication (CEA) Product
 Table 129. George Clinical Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 130. George Clinical Recent Development
 Table 131. Cardialysisv Company Details
 Table 132. Cardialysisv Business Overview
 Table 133. Cardialysisv Clinical Endpoint Adjudication (CEA) Product
 Table 134. Cardialysisv Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 135. Cardialysisv Recent Development
 Table 136. ITREAS Company Details
 Table 137. ITREAS Business Overview
 Table 138. ITREAS Clinical Endpoint Adjudication (CEA) Product
 Table 139. ITREAS Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 140. ITREAS Recent Development
 Table 141. Exom Group Company Details
 Table 142. Exom Group Business Overview
 Table 143. Exom Group Clinical Endpoint Adjudication (CEA) Product
 Table 144. Exom Group Revenue in Clinical Endpoint Adjudication (CEA) Business (2019-2024) & (US$ Million)
 Table 145. Exom Group Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. Clinical Endpoint Adjudication (CEA) Picture
 Figure 2. Global Clinical Endpoint Adjudication (CEA) Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Clinical Endpoint Adjudication (CEA) Market Share by Type: 2023 VS 2030
 Figure 4. Efficacy Endpoints Features
 Figure 5. Safety Endpoints Features
 Figure 6. Global Clinical Endpoint Adjudication (CEA) Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Clinical Endpoint Adjudication (CEA) Market Share by Application: 2023 VS 2030
 Figure 8. Drug Clinical Trials Case Studies
 Figure 9. Medical Device Clinical Trials Case Studies
 Figure 10. Others Case Studies
 Figure 11. Clinical Endpoint Adjudication (CEA) Report Years Considered
 Figure 12. Global Clinical Endpoint Adjudication (CEA) Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 13. Global Clinical Endpoint Adjudication (CEA) Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Clinical Endpoint Adjudication (CEA) Market Share by Region: 2023 VS 2030
 Figure 15. Global Clinical Endpoint Adjudication (CEA) Market Share by Players in 2023
 Figure 16. Global Top Clinical Endpoint Adjudication (CEA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Endpoint Adjudication (CEA) as of 2023)
 Figure 17. The Top 10 and 5 Players Market Share by Clinical Endpoint Adjudication (CEA) Revenue in 2023
 Figure 18. North America Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 19. North America Clinical Endpoint Adjudication (CEA) Market Share by Country (2019-2030)
 Figure 20. United States Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Clinical Endpoint Adjudication (CEA) Market Share by Country (2019-2030)
 Figure 24. Germany Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. France Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. U.K. Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Italy Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Russia Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Nordic Countries Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Clinical Endpoint Adjudication (CEA) Market Share by Region (2019-2030)
 Figure 32. China Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Japan Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. South Korea Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Southeast Asia Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. India Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Australia Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Clinical Endpoint Adjudication (CEA) Market Share by Country (2019-2030)
 Figure 40. Mexico Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Brazil Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Clinical Endpoint Adjudication (CEA) Market Share by Country (2019-2030)
 Figure 44. Turkey Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Saudi Arabia Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. UAE Clinical Endpoint Adjudication (CEA) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. ICON Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 48. Medidata Solutions Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 49. Clario Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 50. Syneos Health Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 51. Advarra Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 52. Medpace Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 53. Sitero Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 54. WCG Clinical Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 55. Voiant Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 56. IQVIA Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 57. Ethical Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 58. Banook Group Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 59. Judi for Adjumination Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 60. CISYS LifeSciences Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 61. Crucial Data Solutions Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 62. TCell Clinical Services Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 63. George Clinical Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 64. Cardialysisv Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 65. ITREAS Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 66. Exom Group Revenue Growth Rate in Clinical Endpoint Adjudication (CEA) Business (2019-2024)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Endpoint Adjudication Service Market Research Report 2024
Global Clinical Trial Adjudication Service Market Research Report 2024
Global Medical Devices Clinical Trials Market Research Report 2025
Global E Clinical Software Market Research Report 2024
Global Imaging In Clinical Trials Market Research Report 2024
Global eCOA eSource Clinical Trials Market Research Report 2024
Global Oncology Clinical Trial Market Research Report 2024
Global Clinical Safety and Pharmacovigilance Services Market Research Report 2024
Global Clinical Development Strategy Market Research Report 2024
E Clinical Solution Software
Global Clinical Documentation Software Market Insights Forecast to 2030
Global CEA Test Kits Market Research Report 2024
Global Clinical Biomarker Testing Market Research Report 2024
Global Clinical Data Analytics in Healthcare Market Insights Forecast to 2030
Global ePRO E Patient Diaries and eCOA Market Insights Forecast to 2030
Global Clinical DNA Test Market Research Report 2024
Global Clinical Trial Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Cardiac Safety Assessment Services Market Research Report 2025
Clinical Contract Research Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Endotherapy Devices Market Research Report 2024

RELATED REPORTS

Global Stem Cell Therapy for Multiple Sclerosis Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35H13194
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Circulating Tumor Cells and Cancer Stem Cells Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30P9123
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Stem Cell Umbilical Cord Blood Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Othe-477
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Oncology Information System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9W6217
Fri Sep 05 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions